Pathway Financial Advisers, LLC Astrazeneca PLC Transaction History
Pathway Financial Advisers, LLC
- $196 Billion
- Q3 2024
A detailed history of Pathway Financial Advisers, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Pathway Financial Advisers, LLC holds 22,126 shares of AZN stock, worth $1.45 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,126
Previous 284
7690.85%
Holding current value
$1.45 Million
Previous $22.2 Million
98.72%
% of portfolio
0.0%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding AZN
# of Institutions
1,359Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.13 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.76 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.44 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.42 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.3MShares$1.27 Billion0.43% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $203B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...